Investigating how changes in IgG glycosylation affect kidney injury in lupus nephritis
IgG glycosylation in lupus nephritis
This study is looking at how certain changes in antibodies might affect kidney health in people with lupus nephritis, hoping to find new ways to prevent kidney damage for those dealing with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11080116 on NIH RePORTER |
What this research studies
This research focuses on lupus nephritis, a severe kidney complication affecting many patients with systemic lupus erythematosus. It aims to identify specific changes in the glycosylation of IgG antibodies in patients with lupus nephritis compared to those without. By understanding how these altered antibodies interact with kidney cells, the study seeks to uncover mechanisms that lead to kidney damage. The research involves characterizing IgG glycosylation patterns and exploring the signaling pathways that contribute to kidney injury, potentially leading to new preventive strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with systemic lupus erythematosus, particularly those who are at risk of developing lupus nephritis.
Not a fit: Patients with lupus who do not have systemic lupus erythematosus or those without any kidney involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for patients at risk of developing kidney complications from lupus.
How similar studies have performed: Previous research has shown promising results in understanding the role of glycosylation in autoimmune diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Bhargava, Rhea — Tulane University of Louisiana
- Study coordinator: Bhargava, Rhea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.